Vertex, U.K. reach reimbursement deal for CRISPR-based medicine for sickle cell disease
People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the U.K. and Vertex.
People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the U.K. and Vertex.
Findings suggest the benefits of combined belatacept and tacrolimus immunosuppression after kidney transplantation for patient and all-cause graft survival.
Objective Glyphosate is widely used in Malaysian agriculture but poses a significant under-reported public health concern due to poisoning. This paper aims to study the…
Comcast’s broadband customers declined more than anticipated, sending shares plunging Thursday.
Lily Vittayarukskul (pictured above) was studying aerospace engineering when her aunt was diagnosed with terminal colon cancer. Post-chemotherapy, Vittayarukskul’s aunt “became very frail,” so her…
India’s Jubilant Pharmova reported a 51% jump in third-quarter profit on Friday, driven by a strong demand for its drugs with radioactive ingredients, used to…
There are 100 of Avride’s newest model on The Ohio State University’s campus.
Asteroid 2024 YR4 rises to top of impact risk lists after being spotted in December by automated telescope in Chile
This e-book provides information about the advantages and disadvantages of different activity tracking solutions in research use. The guide is not a systematic review but…
Australian hospital operator Ramsay Health Care said on Friday its group chief financial officer, Martyn Roberts, had resigned after five years with the company, to…
Google is testing a new “Ask for Me” feature that uses AI to call local businesses on your behalf, for information about availability and pricing.…